Neuraxis highlights strength of its board of directors

Carmel, ind., aug. 24, 2023 (globe newswire) -- neuraxis, inc. (nyse american: nrxs), (“neuraxis,” or the “company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today highlighted the strength of its board of directors.
NRXS Ratings Summary
NRXS Quant Ranking